XM tidak menyediakan perkhidmatan kepada penduduk Amerika Syarikat.

Futures dip as investors gear up for key inflation report



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-Futures dip as investors gear up for key inflation report</title></head><body>

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.

Bristol-Myers Squibb gains after FDA approves schizophrenia drug

Costco Wholesale slips after Q4 revenue misses estimates

Futures off: Dow 0.05%, S&P 500 0.12%, Nasdaq 0.26%

Updated at 6:58 a.m. ET/1058 GMT

By Johann M Cherian and Purvi Agarwal

Sept 27 (Reuters) -U.S. stock index futures inched lower onFriday, as investors refrained from placing big bets aheadof a crucial inflation report which could sway expectations on the size of upcoming interest rate cuts by the Federal Reserve.

The Commerce Department's report, due at 8:30 a.m. ET, is expected to show the personal consumption expenditure index - the Fed's preferred inflation gauge - rose by 2.3% in August, according to economists polled by Reuters, down from 2.5% the month before.

Inflation moderating towards the central bank's 2% target gave the Fed enough room to commence its policy easing cycle with a 50 basis point rate cut last week. Ensuring that unemployment rates do not shoot up will be its focus now.

"Even in the case of a small deviation from consensus, the recent shift in the Fed's focus to the employment side of its mandate means markets are less sensitive to inflation news," strategists at ING Bank said.



Data through the week points to a still-resilienteconomy overall, leaving traders uncertain about the Fed's next move. Odds of anotheroutsized move at the central bank'sNovember meeting stand at 50.8%, as per the CME Group's FedWatch Tool. Those for a 25 bps reduction stand at 49.2%.

At 6:58 a.m. ET, Dow E-minis 1YMcv1 were down 22 points, or 0.05%, S&P 500 E-minis EScv1 were down 7 points, or 0.12% and Nasdaq 100 E-minis NQcv1 were down 53.75 points, or 0.26%.

Futures tied to the Russell 2000 index RTYc1, which tracks small caps, were 0.2% higher.

The University of Michigan's final September estimate on consumer sentiment and remarks from Fed Governor Michelle Bowman are also in focus on the day.

Late on Thursday, Fed Governor Lisa Cook said the central bank's rare move earlier this month could address increased "downside risks" to employment.

Wall Street's main indexes ended higher in the previous session, with the S&P 500 .SPX closing at its highest levels on record after an upbeat forecast from Micron MU.O invigorated optimism around artificial intelligence.

The benchmark index along with the blue-chip Dow .DJI and tech-heavy Nasdaq are on track for their third-straight week of gains.

Among other stocks, Bristol Myers Squibb BMY.N surged 6% after the U.S. FDA approved its schizophrenia drug, providing patients with a treatment option that reduces symptoms of the mental disorder without common side effects.

Costco Wholesale COST.O dropped 1.3% after missing market expectations for fourth-quarter revenue, hurt by cautious consumer spending on pricier items at its membership-only stores and lower gasoline prices.

Dollar General DG.N slipped 2.1% after Citigroup downgraded the discount retail chain to "sell" from "neutral".

U.S.-listed shares of Chinese firms such as Alibaba BABA.N rose 0.7%, PDD Holdings PDD.O climbed 2.2% and NetEase NTES.O gained 2.1% trackingdomestic stocks after China's central bank lowered interest rates and injected liquidity into the banking system, in its latest stimulus move.

Miners such as Albemarle ALB.N added 2.8% and U.S.-listed shares of BHP BHP.N rose 1% after a report showed top Chinese cities Shanghai and Shenzhen are planning to lift key remaining restrictions on home purchases to attract potential buyers.


PCE, the shorter term view https://reut.rs/3WXgbkd


Reporting by Johann M Cherian and Purvi Agarwal in Bengaluru; Editing by Anil D'Silva and Maju Samuel

</body></html>

Penafian: Entiti XM Group menyediakan perkhidmatan pelaksanaan sahaja dan akses ke Kemudahan Dagangan Atas Talian, yang membolehkan sesorang melihat dan/atau menggunakan kandungan yang ada di dalam atau melalui laman web, tidak bertujuan untuk mengubah atau memperluas, juga tidak mengubah atau mengembangkannya. Akses dan penggunaan tersebut tertakluk kepada: (i) Terma dan Syarat; (ii) Amaran Risiko; dan Penafian Penuh. Oleh itu, kandungan sedemikian disediakan tidak lebih dari sekadar maklumat umum. Terutamanya, perlu diketahui bahawa kandungan Kemudahan Dagangan Atas Talian bukan permintaan, atau tawaran untuk melakukan transaksi dalam pasaran kewangan. Berdagang dalam mana-mana pasaran kewangan melibatkan tahap risiko yang besar terhadap modal anda.

Semua bahan yang diterbitkan di Kemudahan Dagangan Atas Talian kami bertujuan hanya untuk tujuan pendidikan/maklumat dan tidak mengandungi – dan tidak boleh dianggap mengandungi nasihat kewangan, cukai pelaburan atau dagangan dan cadangan, atau rekod harga dagangan kami, atau tawaran, atau permintaan untuk suatu transaksi dalam sebarang instrumen kewangan atau promosi kewangan yang tidak diminta kepada anda.

Sebarang kandungan pihak ketiga serta kandungan yang disediakan oleh XM, seperti pendapat, berita, penyelidikan, analisis, harga, maklumat lain atau pautan ke laman web pihak ketiga yang terdapat dalam laman web ini disediakan berdasarkan "seadanya" sebagai ulasan pasaran umum dan bukanlah nasihat pelaburan. Sesuai dengan apa-apa kandungan yang ditafsir sebagai penyelidikan pelaburan, anda mestilah ambil perhatian dan menerima bahawa kandungan tersebut tidak bertujuan dan tidak sediakan berdasarkan keperluan undang-undang yang direka untuk mempromosikan penyelidikan pelaburan bebas dan oleh itu, ia dianggap sebagai komunikasi pemasaran di bawah peraturan dan undang-undang yang berkaitan. SIla pastikan bahawa anda telah membaca dan memahami Notifikasi mengenai Penyelidikan Pelaburan Bukan Bebas dan Amaran Risiko mengenai maklumat di atas yang boleh diakses di sini.

Amaran Risiko: Modal anda dalam risiko. Produk yang berleveraj mungkin tidak sesuai untuk semua individu. Sila pertimbangkan Pendedahan Risiko kami.